Open Internet by MindsNet

Identifying bottlenecks in translating promising biology into first-in-human trials

Many promising biology programs from academia and early preclinical research fail to progress to first-in-human trials. The question is at what stage and why these programs get dropped, especially when they are IND-ready and have de-risked tox.

Science, Biology, Biotechnology